l-Arginine promotes angiogenesis in the chronically hypoxic lung: a novel mechanism ameliorating pulmonary hypertension
Authors:
- C. M. CostelloCCC. M. Costello
- M. SandsMSM. Sands
- I. DooleyIDI. Dooley
- P. McLoughlinPMP. McLoughlin
Open Access
- 1 June 2009
- journal article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 296 (6) , L1042-L1050
Abstract
Chronic alveolar hypoxia, whether due to residence at high altitude or lung disease, leads to a sustained increase in pulmonary vascular resistance and pulmonary hypertension (PH). Strategies that augment endogenous nitric oxide production or activity, including l-arginine supplementation, attenuate the development of PH. This action has been attributed to inhibition of vessel wall remodeling, thus preventing structural narrowing of the vascular lumen. However, more recent evidence suggests that structural changes are not responsible for the elevated vascular resistance observed in chronic hypoxic PH, calling into question the previous explanation for the action of l-arginine. We examined the effect of dietary l-arginine supplementation on pulmonary vasoconstriction, structurally determined maximum vascular lumen diameter, and vessel length in rats during 2 wk of exposure to hypoxia. l-Arginine attenuated the development of hypoxic PH by preventing increased arteriolar resistance. It did not alter mean maximal vascular lumen diameter, nor did it augment nitric oxide-mediated vasodilatation, in chronically hypoxic lungs. However, the total length of vessels within the gas exchange region of the hypoxic lungs was significantly increased after l-arginine supplementation. These findings suggest that dietary l-arginine ameliorated hypoxic PH, but not by an effect on the structurally determined lumen diameter of pulmonary blood vessels. l-Arginine enhanced angiogenesis in the hypoxic pulmonary circulation, which may attenuate hypoxic PH by producing new parallel vascular pathways through the lung.Keywords
This publication has 74 references indexed in Scilit:
- SDF-1α/CXCR4 decreases endothelial progenitor cells apoptosis under serum deprivation by PI3K/Akt/eNOS pathwayAtherosclerosis, 2008
- Last Word on Point:Counterpoint “Chronic hypoxia-induced pulmonary hypertension does/does not lead to loss of pulmonary vasculature”Journal of Applied Physiology, 2007
- Point:Counterpoint: Chronic hypoxia-induced pulmonary hypertension does/does not lead to loss of pulmonary vasculatureJournal of Applied Physiology, 2007
- Regression of chronic hypoxic pulmonary hypertension by simvastatinAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2007
- Rho Kinase–Mediated Vasoconstriction Is Important in Severe Occlusive Pulmonary Arterial Hypertension in RatsCirculation Research, 2007
- Protective effect of arginine on oxidative stress in transgenic sickle mouse modelsFree Radical Biology and Medicine, 2006
- Simvastatin causes endothelial cell apoptosis and attenuates severe pulmonary hypertensionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2006
- BMPR-IIheterozygous mice have mild pulmonary hypertension and an impaired pulmonary vascular remodeling response to prolonged hypoxiaAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2004
- Evidence for Dysregulation of Dimethylarginine Dimethylaminohydrolase I in Chronic Hypoxia–Induced Pulmonary HypertensionCirculation, 2003
- Effect of L-Arginine Infusion on Infants with Persistent Pulmonary Hypertension of the NewbornNeonatology, 1995